Drug discovery

#Drug development #Drug discovery #Drug safety #Drug screening #Mitochondria #Toxicology

App Note: Measure mitochondrial toxicity using primary hepatocytes

Mitochondrial dysfunction is known to play a central role in drug-induced hepatotoxicity, and thus early detection of mitochondrial toxicity is a critical component of initial drug development efforts. While immortalised cell lines are widely used for in vitro assessment of hepatotoxicity, cryopreserved primary human hepatocytes are a preferred model for drug… Read More

#News

#Drug development #Drug discovery #Drug safety #Drug screening #Mitochondria #Toxicology

Measurement of mitochondrial toxicity using primary hepatocytes

Mitochondrial dysfunction is known to play a central role in drug-induced hepatotoxicity, and thus early detection of mitochondrial toxicity is a critical component of initial drug development efforts. While immortalised cell lines are widely used for in vitro assessment of hepatotoxicity, cryopreserved primary human hepatocytes are a preferred model for drug… Read More

#Resources

Active nerve cells
#Drug discovery #Neurodegenerative disorders #Neuroinflammation #Neurology #Neuroscience #Webinar

Innovative advances in neuroscience

In this webinar, hosted by DDW and sponsored by ACROBiosystems, you will learn about the innovative advances in neuroscience. You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at… Read More

Webinar date:
Sponsored by ACROBiosystems
#Webinars

Molecule concept biology
#Biomarkers #Drug discovery #Market reporting #Spatial biology

DDW Fall issue out now

The Fall issue of Drug Discovery World (DDW) is out now featuring expertise on what spatial biology tells us about drug discovery and disease. Read the digital version free here. Other features in the Fall issue include: How biomarkers can help discover new treatments for women’s health A market report… Read More

#News

#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Webinar on benefits and innovation in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

Synthetic DNA molecule
#Drug discovery #In Focus Report #Synthetic biology #Synthetic DNA

In depth eReport on Synthetic Biology: Is it the next big thing?

Synthetic biology has shown significant potential to the drug discovery sector. Although not a new area of science, the prominence of this technology and its applications – evident during the Covid-19 pandemic – have increased of late. This has created advances in the development of new medicines and our… Read More

#Editor's Choice #News

#Covid-19 vaccine #Drug development #Drug discovery #Immunology / Virology & Vaccines #Vaccines

New DDW Highlights podcast out now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  As we approach another autumn/winter season in the northern hemisphere, Covid-19 vaccines… Read More

#News

#Drug discovery #In Focus Report #Synthetic biology #Synthetic DNA

Synthetic Biology: Is it the next big thing?

Download this exclusive DDW eReport to learn more about: The global market for synthetic biology: its potential and where innovative drug development is taking place Analysis of regional markets and the key players within the synthetic biology sector How advances in the synthetic biology field are impacting drug discovery – from… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Covid-19 vaccine #Drug development #Drug discovery #Immunology / Virology & Vaccines #Vaccines

This week in drug discovery (18-22 September)  

News round-up for 18-22 September by DDW Digital Content Editor Diana Spencer. As we approach another autumn/winter season in the northern hemisphere, Covid-19 vaccines are once again making the headlines, but in the last week we have also reported on vaccine trials for a number of… Read More

#News

#Alzheimer's #Drug discovery #Neurodegenerative disorders #Neurology

Study opens up new therapeutic pathways in Alzheimer’s disease 

A research team from VIB-KU Leuven and the UK Dementia Research Institute has discovered how neurons die in Alzheimer’s disease, opening new pathways for potential future treatments.  A new research paper published in Science illustrates how neurons initiate a programmed form of cell death, known… Read More

#News

Human cell
#Appointment #Biotech #Drug discovery #Single-cell analysis

Cytomos appoints new director to assist commercialisation strategy  

Biotech company Cytomos has appointed a new Non-Executive Director in a bid to help accelerate plans to brings its cell analysis technology to market.   Dr Sharon Brownlow has joined as Non-Executive Director and will play a key role in helping Cytomos bring its Dielectric Spectroscopy (CDS)… Read More

#News

Next generation sequencing
#Drug discovery #In Focus Report #NGS

DDW In Focus eReport: The impact of NGS on drug discovery

Created by DDW and sponsored by Tecan, ‘The Rise of NGS and its impact on drug discovery’ is a free In Focus report available here.  Download this In Focus eReport to learn more about the landscape of next generation sequencing (NGS) and how it is impacting drug discovery and… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Generative AI #Webinar

Generative AI: Turning drug discovery into a technological pursuit

This webinar, supported by Thermo Fisher Scientific and presented by Generate:Biomedicines, is now available to view on-demand. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an integrated approach of using Cryo-EM with ML methods has the… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Bottles of pills
#Cancer research #Drug development #Drug discovery #Oncology #Screening

Identify metabolic target pathways in cancer drug discovery

The regulation of cellular bioenergetics is recognised as a key driver of cancer cell proliferation. Identifying key pathways that modulate bioenergetic metabolism is a promising strategy for developing novel therapeutics for cancer treatment. Discover more in this new App Note from Agilent entitled ‘Rapid Bioenergetic Functional Screening of Anticancer Drug… Read More

#News

#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

The benefits and innovations in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News